from Reuters: Health News https://ift.tt/2KZB76f
Tuesday, 27 August 2019
U.S. FDA grants orphan drug status to AstraZeneca's asthma drug Fasenra
AstraZeneca said on Wednesday that the U.S. Food and Drug Administration has granted orphan drug status to its severe asthma drug, Fasenra, to treat eosinophilic oesophagitis (EoE).
from Reuters: Health News https://ift.tt/2KZB76f
from Reuters: Health News https://ift.tt/2KZB76f
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment